Peter Slover
Vermogen: 54 775 $ op 30-06-2026
Vermogen: 54 775 $ op 30-06-2026
Mr. Peter T.
Slover, CPA, is a Chief Financial & Accounting Officer at Contineum Therapeutics, Inc. Mr. Slover was previously employed as a Chief Financial & Accounting Officer by Sophiris Bio, Inc., a Vice President-Finance & Operations by Anadys Pharmaceuticals, Inc., and an Auditor by KPMG LLP.
He received his undergraduate degree from Shippensburg University of Pennsylvania.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-04-2026 | 3.342 ( 0,01% ) | 54 775 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-09-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SOPHIRIS BIO | Financieel Directeur/CFO | 01-05-2020 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Financieel Directeur/CFO | - |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01-01-2004 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Shippensburg University of Pennsylvania
Shippensburg University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau